Skip to main content
Equibles
BAX logo

BAX · Baxter International Inc · Earnings Call Transcripts & Audio

Track BAX — free

Use BAX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BAX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$22.93 +0.13 (+0.57%) At close · Sep 21
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$12.26B
Shares
517.00M

Baxter International Inc Earnings Call Transcripts

Quarterly earnings calls for Baxter International Inc (BAX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲11.9% $3.61B −$2.94B '22 Q3 22-10-27 ▲30.2% $3.75B $181.00M '22 Q4 23-02-09 ▼31.4% $2.44B $44.00M '23 Q1 23-04-27 ▼27.9% $2.59B −$141.00M '23 Q2 23-07-27 ▼28% $2.60B $2.51B '23 Q3 23-11-02 ▼27.1% $2.73B $245.00M '23 Q4 24-02-08 ▲2% $2.49B $37.00M '24 Q1 24-05-02 ▲4% $2.69B −$314.00M '24 Q2 24-08-06 ▲3.8% $2.70B $140.00M '24 Q3 24-11-08 ▲0.9% $2.75B −$512.00M '24 Q4 25-02-03 ▲5.4% $2.62B $126.00M '25 Q1 25-05-01 ▲4.3% $2.81B $91.00M '25 Q2 25-07-31 ▲5% $2.83B −$46.00M '25 Q3 25-10-30 ▲8% $2.97B −$1.13B '25 Q4 26-02-12 ▲2.9% $2.70B −$15.00M '26 Q1 26-04-30 LATEST ▲5.3% $2.96B $126.00M '26 Q2 26-07-30
Earnings call
FY26 · Q2
2026-07-30
Baxter International Inc (BAX) Q2 2026 Earnings Call Transcript
Positive tone Strategic priorities and turnaround Tariff refund and EPS outlook Organic revenue growth and Q2 results
Revenue
$2.96B
▲ 5.3% YoY
Diluted EPS
$0.24
▲ 33.3% YoY
Gross margin
34.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-09
Baxter International Inc (BAX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Annual General Meeting
Investor event
2026-05-05
Baxter International Inc (BAX) May 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-30
Baxter International Inc (BAX) Q1 2026 Earnings Call Transcript
Positive tone Novum LVP field actions and remediation Leadership and CFO search Balance sheet and cash flow / leverage
Revenue
$2.70B
▲ 2.9% YoY
Diluted EPS
$-0.03
▼ 112% YoY
Gross margin
33.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-11
Baxter International Inc (BAX) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-12
Baxter International Inc (BAX) Q4 2025 Earnings Call Transcript
Cautious tone 2026 guidance and macro/tariffs Balance sheet and deleveraging Operating model restructuring
Revenue
$2.97B*
▲ 8% YoY
Gross margin
19.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-30
Baxter International Inc (BAX) Q3 2025 Earnings Call Transcript
Cautious tone CEO transition and stabilization Fluid conservation and inventory Balance sheet and dividend cut
Revenue
$2.83B
▲ 5% YoY
Diluted EPS
$-0.09
▼ 133.3% YoY
Gross margin
33.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
Baxter International Inc (BAX) Q2 2025 Earnings Call Transcript
Cautious tone Operating margin / cost pressure IV fluid conservation North Cove / Vizient partnership
Revenue
$2.81B
▲ 4.3% YoY
Diluted EPS
$0.18
Gross margin
35.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Baxter International Inc (BAX) Q1 2025 Earnings Call Transcript
Positive tone Kidney Care / Vantive divestiture 2025 financial outlook Hurricane Helene / North Cove IV recovery
Revenue
$2.62B
▲ 5.4% YoY
Diluted EPS
$0.25
▲ 257.1% YoY
Gross margin
32.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-03
Baxter International Inc (BAX) Q4 2024 Earnings Call Transcript
Confident tone 2024 results and 2025 outlook Hospital products and therapies segments North Cove hurricane recovery
Revenue
$2.75B
▲ 0.9% YoY
Diluted EPS
$-1.00
▼ 308.3% YoY
Gross margin
34.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-08
Baxter International Inc (BAX) Q3 2024 Earnings Call Transcript
Positive tone Kidney Care Divestiture 2025 Financial Outlook North Cove Hurricane Recovery
Revenue
$2.70B
▲ 3.8% YoY
Diluted EPS
$0.27
▼ 94.5% YoY
Gross margin
38.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Baxter International Inc (BAX) Q2 2024 Earnings Call Transcript
Positive tone Strategic transformation and Kidney Care separation 2025 outlook and exit rate Front Line Care / primary care softness
Revenue
$2.69B
▲ 4% YoY
Diluted EPS
$-0.61
Gross margin
38.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Baxter International Inc (BAX) Q1 2024 Earnings Call Transcript
Positive tone Geographic expansion of Hillrom / HST internationally Margin improvement and supply chain execution Healthcare Systems & Technologies (HST) underperformance
Revenue
$2.49B
▲ 2% YoY
Diluted EPS
$0.07
▼ 22.2% YoY
Gross margin
38.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-08
Baxter International Inc (BAX) Q4 2023 Earnings Call Transcript
Positive tone Pricing and GPO contracts Kidney Care / Vantive separation Segment performance (Medical Products, HST, Pharmaceuticals)
Revenue
$2.73B
▼ 27.1% YoY
Diluted EPS
$0.48
▲ 33.3% YoY
Gross margin
40.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Baxter International Inc (BAX) Q3 2023 Earnings Call Transcript
Revenue
$2.60B
▼ 28% YoY
Diluted EPS
$4.93
Gross margin
40.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
Baxter International Inc (BAX) Q2 2023 Earnings Call Transcript
Revenue
$2.59B
▼ 27.9% YoY
Diluted EPS
$-0.28
▼ 156% YoY
Gross margin
39.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
Baxter International Inc (BAX) Q1 2023 Earnings Call Transcript
Revenue
$2.44B
▼ 31.4% YoY
Diluted EPS
$0.09
▼ 35.7% YoY
Gross margin
39.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-09
Baxter International Inc (BAX) Q4 2022 Earnings Call Transcript
Revenue
$3.75B
▲ 30.2% YoY
Diluted EPS
$0.36
Gross margin
37.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-27
Baxter International Inc (BAX) Q3 2022 Earnings Call Transcript
Revenue
$3.61B
▲ 11.9% YoY
Diluted EPS
$-5.83
▼ 755.1% YoY
Gross margin
29.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Baxter International Inc (BAX) Q2 2022 Earnings Call Transcript
Revenue
$3.59B
▲ 16% YoY
Diluted EPS
$0.50
▼ 15.3% YoY
Gross margin
38.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Baxter International Inc (BAX) Q1 2022 Earnings Call Transcript
Revenue
$3.56B
▲ 20.8% YoY
Diluted EPS
$0.14
▼ 75.9% YoY
Gross margin
35.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
Baxter International Inc (BAX) Q4 2021 Earnings Call Transcript
Revenue
$2.88B*
▼ 9.6% YoY
Gross margin
35.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Baxter International Inc (BAX) Q3 2021 Earnings Call Transcript
Revenue
$3.23B
▲ 8.5% YoY
Diluted EPS
$0.89
▲ 29% YoY
Gross margin
40.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Baxter International Inc (BAX) Q2 2021 Earnings Call Transcript
Revenue
$3.10B
▲ 14% YoY
Diluted EPS
$0.59
▲ 22.9% YoY
Gross margin
39.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Baxter International Inc (BAX) Q1 2021 Earnings Call Transcript
Revenue
$2.95B
▲ 5.1% YoY
Diluted EPS
$0.58
▼ 9.4% YoY
Gross margin
38.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-04
Baxter International Inc (BAX) Q4 2020 Earnings Call Transcript
Revenue
$3.18B
▲ 4.7% YoY
Diluted EPS
$0.33
Gross margin
37.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Baxter International Inc (BAX) Q3 2020 Earnings Call Transcript
Revenue
$2.97B
▲ 4.2% YoY
Diluted EPS
$0.69
▼ 2.8% YoY
Gross margin
40.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Baxter International Inc (BAX) Q2 2020 Earnings Call Transcript
Revenue
$2.72B
▼ 4.1% YoY
Diluted EPS
$0.48
▼ 20% YoY
Gross margin
38.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Baxter International Inc (BAX) Q1 2020 Earnings Call Transcript
Revenue
$2.80B
▲ 6.2% YoY
Diluted EPS
$0.64
▼ 3% YoY
Gross margin
41.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-17
Baxter International Inc (BAX) Q4 2019 Earnings Call
Revenue
$3.04B
▲ 7.3% YoY
Diluted EPS
$-0.05
▼ 108.8% YoY
Gross margin
42.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–30 of 30 earnings calls
Key facts CIK 10456 CUSIP 071813109 13F (30d) 16 filings 14 filers Visit website Investor relations